aDepartment of Biological Psychiatry

bDepartment of Disaster Psychiatry, International Research Institute of Disaster Science (IRIDeS), Graduate School of Medicine, Tohoku University, Sendai

cDepartment of Psychiatry and Behavioral Sciences, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo

dDepartment of Maternal and Fetal Therapeutics

eDepartment of Maternal and Child Healthcare Medical Science, Graduate School of Medicine, Tohoku University, Sendai, Japan

fDepartment of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio

gDepartment of Neuroscience and Pharmacology, Columbia University Medical Center, New York, New York

hDepartments of Neurology and Pharmacology, University of Maryland School of Medicine, and VA Maryland Healthcare System, Baltimore, Maryland, USA

iDepartment of Digital Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan

Received 23 December 2022 Accepted as revised 29 June 2023.

Correspondence to Ichiro Sora, MD, PhD, Department of Digital Psychiatry, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan, E-mail: [email protected]